Skip to main content
OpenTrials
Completed

NCT Number: NCT03099694

NHFOV vs. NCPAP as a Primary Treatment to Neonatal Respiratory Distress Syndrome(NRDS)

The investigators compared advantages and disadvantages of two forms of noninvasive respiratory support -noninvasive high-frequency oscillatory ventilation (nHFOV) or nasal continuous positive airway pressure (nCPAP) -as a primary mode of ventilation in premature infants with RDS.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

Up to 12 hour

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Xingwang Zhu

Chongqing, Chongqing Municipality, 400000, China

About this study

Background: Invasive mechanical ventilation is associated with development of adverse pulmonary and non-pulmonary outcomes in very low birth weight infants. Various modes of non-invasive respiratory support are being increasingly used to minimize the incidence of bronchopulmonary dysplasia (BPD). The aim of this trials to compare the effect of noninvasive high-frequency oscillatory ventilation (NHFOV) and nasal continuous positive airway pressure (NCPAP) in preterm infants with respiratory distress syndrome (RDS) as a primary noninvasive ventilation support mode.

Methods/Design:In this multicenter, randomized, controlled trial, 300 preterm infants at gestational age (GA) less than 34 weeks with a diagnosis of RDS will be randomized to NHFOV or NCPAP as a primary mode of non-invasive respiratory support. Study will be conducted in 18 tertiary neonatal intensive care units in China.

The primary outcome is the need for invasive mechanical ventilation (IMV)during the first 7 days after enrollment in preterm infants randomized to the two groups. The secondary outcomes include days of hospitalization, days on noninvasive respiratory support, days on IMV, days on supplemental oxygen, mortality, need for surfactant, incidence of retinopathy of prematurity(ROP) and bronchopulmonary dysplasia(BPD), occurrence of abdominal distention, air leaks, intraventricular hemorrhage (IVH ≥ grade 3) and necrotizing enterocolitis (NEC> II stage). Other secondary outcomes include scores of Bayley Scales of Infant Development at 2 months and 2 years of corrected age.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

(1)Gestational age (GA) is from 26 to 34 weeks; (2) diagnosis of RDS. The diagnosis of RDS will be based on clinical manifestations (tachypnea, nasal flaring and or grunting) and chest X-ray findings; (3) RDS Silverman score>5; (4) informed parental consent has been obtained.

Exclusion criteria

(1) severe RDS requiring early intubation according to the American Academy of Pediatrics guidelines for neonatal resuscitation7; (2)major congenital malformations or complex congenital heart disease; (3) group B hemolytic streptococcus pneumonia, septicemia, pneumothorax, pulmonary hemorrhage; (4) cardiopulmonary arrest needing prolonged resuscitation; (5) transferred out of the NICUs without treatment.

Treatment and study plan

noninvasive high-frequency ventilation (nHFOV)

Procedure

NHFOV will be provided by a high frequency ventilator (CNO, Medin, Germany or SLE 5000, UK). NHFOV will be provided via binasal prongs.

Nasal continuous positive airway pressure (NCPAP)

Procedure

Infants assigned to the NCPAP group will be started on a pressure of 6 cmH2O (range: 6-8 cmH2O) by CPAP system (CNO Medin, Germany, Carefusion, USA)

Primary outcomes

  1. Number of Participants Who Required Intubation

    Time frame: during the first 7 days after birth

    The criteria for endotracheal mechanical ventilation were as follows: severe respiratory acidosis (PaCO2 > 60 mmHg with pH<7.20), severe apnea and bradycardia (defined as recurrent apnea with > 3 episodes per hour associated with heart rate < 100/min, a single episode of apnea that required bag and mask ventilation), hypoxia (FiO2>0.5 with PaO2<50mmHg), severe respiratory distress, neonatal pulmonary hemorrhage, and cardiopulmonary arrest without effective resuscitation needing continued ventilation and rescue

Secondary outcomes

  1. the Incidence of Intraventricular Hemorrhage (IVH, ≥ Grade Ⅲ)

    Time frame: first two months after birth

    The criteria for intraventricular hemorrhage (IVH, ≥ grade Ⅲ): intraventricular hemorrhage with ventricular dilatation and intraventricular hemorrhage with paren- ehymal hemorrhage. Intraventricular hemorrhage (≥ grade Ⅲ) is worse outcome.

  2. the Incidence of Pneumothorax

    Time frame: during non-invasive ventilation, up to 7 days

    the incidence of pneumothorax

  3. the Incidence of Neonatal Necrotizing Enterocolitis(>Stage II)

    Time frame: during non-invasive ventilation, up to 7 days

    The criteria for neonatal necrotizing enterocolitis(>stage II): Unequivocal malfunction of the gastrointestinal tract is demonstrated clinically and by radiographic evaluation. Other disorders such as malrotation and volvulus and Hirschsprung's disease must be excluded.

    Neonatal necrotizing enterocolitis(>stage II) is worse outcome

  4. the Incidence of Retinopathy of Prematurity (>Stage II)

    Time frame: at a post-menstrual age of 36 weeks or at discharge

    The criteria for Retinopathy of prematurity (>Stage II); extraretinal fibrovascular proliferation neovascularization extends from ridge into the vitreous. Retinopathy of prematurity (>Stage II) is worse outcome.

  5. The Score of Bayley Scales of Infant Development

    Time frame: 30 months

    scores of Bayley Scales of Infant Development at 2 months old and 2 years old

  6. the Incidence of Bronchopulmonary Dysplasia(BPD)

    Time frame: at a post-menstrual age of 36 weeks or at discharge

    BPD was defined according to the National Institutes of Health consensus definition: Need for O2 supplementation(FiO2>0.21) for at least 28 days after birth.

    BPD is worse outcome.

  7. the Incidence of Abdominal Distention

    Time frame: during non-invasive ventilation, up to 7 days

    Abdominal circumference increase 2 centimeter during non-invasive ventilation

  8. The Time of Non-invasive Ventilation

    Time frame: during non-invasive ventilation, up to 30 days

    Hours

  9. Length of Hospitalization

    Time frame: during hospitalization, up to 60 days

    Days

  10. Predischarge Mortality

    Time frame: during hospitalization, up to 60 days

  11. Length of O2 Therapy

    Time frame: during hospitalization, up to 60 days

    Days

  12. Number of Participants With Thick Secretions Causing an Airway Obstruction

    Time frame: during non-invasive ventilation, up to 15 days

    determined by the clinician

Sponsors and collaborators

Lead sponsor

Xingwang Zhu

Other

Collaborators

  • Chengdu Women's and Children's Central Hospital
  • Children's Hospital of Chongqing Medical University
  • Children's Hospital of Fudan University
  • Chongqing Maternal and Child Health Hospital
  • Chongqing Three Gorges Central Hospital
  • Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
  • Guangdong Women and Children Hospital
  • Guiyang Maternity and Child Health Care Hospital
  • Hunan Children's Hospital
  • Kunming Children's Hospital
  • Nanjing Children's Hospital
  • Shanxi Provincial Maternity and Children's Hospital
  • The Children's Hospital of Zhejiang University School of Medicine
  • The People's Hospital of Dehong Autonomous Prefecture
  • The Second Hospital of Shandong University
  • University of Southern California
  • Vilnius University
  • Yan'an Affiliated Hospital of Kunming Medical University
  • Zhengzhou Children's Hospital, China

Registry information

Official study title

Noninvasive Ventilation for Preterm Neonates With Respiratory Distress Syndrome: a Multi-center Randomized Controlled Trial

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Apr 4, 2017
Registry last updated
Mar 2, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.